Save information for later
Sign Up

Learn About Familial Colorectal Cancer

What is the definition of Familial Colorectal Cancer?
Familial colon cancer is a cluster of colon cancer within a family. Most cases of colon cancer occur sporadically in people with little to no family history of the condition. Approximately 3-5% of colon cancer is considered "hereditary" and is thought to be caused by an inherited predisposition to colon cancer that is passed down through a family in an autosomal dominant or autosomal recessive manner. In some of these families, the underlying genetic cause is not known; however, many of these cases are caused by changes in the APC, MYH, MLH1, MSH2, MSH6, PMS2, EPCAM, PTEN, STK11, SMAD4, BMPR1A, NTHL1, POLE, and POLD1 genes (which are associated with hereditary cancer syndromes). An additional 10-30% of people diagnosed with colon cancer have a significant family history of the condition but have no identifiable genetic change in a gene known to cause a hereditary predisposition to colon cancer. These clusters of colon cancer are likely due to a combination of gene(s) and other shared factors such as environment and lifestyle.
What are the alternative names for Familial Colorectal Cancer?
  • Familial colorectal cancer
  • Colorectal cancer, familial
Who are the top Familial Colorectal Cancer Local Doctors?
Elite in Familial Colorectal Cancer
Oncology | Hematology Oncology
Elite in Familial Colorectal Cancer
Oncology | Hematology Oncology

City Of Hope Medical Foundation

209 Fair Oaks Ave, 
South Pasadena, CA 
Languages Spoken:
English
Offers Telehealth

Marwan Fakih is an Oncologist and a Hematologist Oncology provider in South Pasadena, California. Dr. Fakih is rated as an Elite provider by MediFind in the treatment of Familial Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, Endoscopy, and Colonoscopy.

John L. Hopper
Elite in Familial Colorectal Cancer
Elite in Familial Colorectal Cancer
207 Bouverie Street, 
Carlton, VIC, AU 

John Hopper practices in Carlton, Australia. Mr. Hopper is rated as an Elite expert by MediFind in the treatment of Familial Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Jenny C. Claude-Chang
Elite in Familial Colorectal Cancer
Elite in Familial Colorectal Cancer
Hamburg, HH, DE 

Jenny Claude-Chang practices in Hamburg, Germany. Ms. Claude-Chang is rated as an Elite expert by MediFind in the treatment of Familial Colorectal Cancer. Her top areas of expertise are Colorectal Cancer, Breast Cancer, Familial Colorectal Cancer, Hormone Replacement Therapy (HRT), and Colonoscopy.

What are the latest Familial Colorectal Cancer Clinical Trials?
Pilot Single-Arm, Pragmatic Trial of In-Home Versus In-Clinic Subcutaneous Nivolumab Administration Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Summary: This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of life. Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar surroundings for many hours per day. This separation adds to the physical, emotional, soci...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Deferred Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After NED in Colorectal Cancer: A Phase II, Single-Arm Clinical Trail.

Summary: Colorectal cancer (CRC) is the third most common cancer worldwide. Surgical resection is one of the primary treatment options for CRC; however, postoperative recurrence remains a significant clinical challenge for both the medical community and patients. Postoperative chemotherapy, as an important adjuvant therapy, is widely used in CRC patients aiming to reduce the risk of recurrence. Despite ext...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center